Serena Scollen
Serena is the Head of Human Genomics and Translational Data at ELIXIR, the European infrastructure for bioinformatics and life-science data, based in Hinxton, UK. She is working with scientists across Europe to establish standards and infrastructure to facilitate discoverability, access, sharing and analysis of genomics data, linked to other data types and at a scale that has not previously been achieved. Developing infrastructure will unleash new possibilities for genomics and health. Serena is the coordinator of the GDI project, a €4oM Digital Europe project and the B1MG project, a €4M EU H2020 Coordination and Support Action that are aligned with the 1+ Million Genomes Initiative (1+MG). This initiative is a commitment of 24 European countries to give cross-border access to one million sequenced genomes by 2022. She is also on the Scientific Advisory Board for Sosei Heptares and Health-RI and European Board for Movement Heath 2030.
Prior to joining ELIXIR, she was a Director within the Human Genetics and Computational Biomedicine group at Pfizer. Earlier in her career, she worked within the Toxicogenomics group at GlaxoSmithKline. She gained postdoctoral experience at the University of Cambridge and Imperial College London and a PhD from the University of Cambridge, with a focus on the genetic susceptibility to disease.
Sessions
-
Building Europe’s Federated Genomics Infrastructure: From Technical Foundations to Data at Scale28-Jan-2027Biodata Stage